QuickView for TK25;jsessionid=8C2ED186389585582270DBD8CC23FC32;jsessionid=C439A3630DFE84B14D178D7B14E67477;jsessionid=32A040510011EF6DFC14728E88EDFB9C;jsessionid=067AA606A93E0A10F9BE6A308784DE18;jsessionid=9A237108E3B44F88910622EB46DBF280 (gene)

1. Effect of FGFR2 Alterations on Overall and Progression-Free Survival in Patients Receiving Systemic …
2. Noninvasive Detection of Polyclonal Acquired Resistance to FGFR Inhibition in Patients With Cholangi…
3. Fgfr2 is integral for bladder mesenchyme patterning and function.
4. Keratinocyte growth factor receptor: a therapeutic target in solid cancer.
5. Pemigatinib: Hot topics behind the first approval of a targeted therapy in cholangiocarcinoma.

There were no clinical trials for TK25;jsessionid=8C2ED186389585582270DBD8CC23FC32;jsessionid=C439A3630DFE84B14D178D7B14E67477;jsessionid=32A040510011EF6DFC14728E88EDFB9C;jsessionid=067AA606A93E0A10F9BE6A308784DE18;jsessionid=9A237108E3B44F88910622EB46DBF280